Metabolically engineered microorganisms
US9688954B2 · kind B2 · utility
0Cited by
7References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 29, 2015 |
| Grant date | Jun 27, 2017 |
| Priority date | — |
| Expiry date | Jan 29, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the enzymatic synthesis of oligosaccharides, particularly, sialylated oligosaccharides comprising the carbohydrate moeities of the gangliosides GM3, GD3, and GT3.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.